Diligence memo · auto-generated · as of July 2, 2026
RIMSYS Inc.
RIMSYS Inc. looks under-valued against its niche peers and is quiet on financing cadence.
Businessfiled
RIMSYS Inc. operates in Other Health Care, based in PITTSBURGH.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
RIMSYS Inc. has raised $24M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $16M on 2021-11-19.
Most recent recorded round closed around 2024-03-28.
Valuation (modeled)modeled
Provath models RIMSYS Inc. at approximately $38M (range $12M–$71M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.25× the median modeled value of Series B Other Health Care companies in 2022–2024 (91 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 16 months.
Last raise 2.3 yr ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
The last round was 3.0× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 86% of Other Health Care peers (5377 compared).
Modeled value ranks above 63% of those peers.
Closest niche peers: Code Biotherapeutics, Inc., Candesant Biomedical, Inc., Artis Holdings, LLC, GIO Blood Ltd, Clarapath, Inc..
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.